Aptorum Group Ltd Class A Asset Resilience Ratio
Aptorum Group Ltd Class A asset resilience ratio. Aptorum Group Ltd Class A (APM) has an Asset Resilience Ratio of 0.00% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Aptorum Group Ltd Class A (APM) liquidity interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Aptorum Group Ltd Class A (2017–2023)
Asset resilience ratio of Aptorum Group Ltd Class A from 2017 to 2023. This chart shows how Aptorum Group Ltd Class A's Asset Resilience Ratio has changed over time. Read Aptorum Group Ltd Class A balance sheet liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Aptorum Group Ltd Class A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see APM total asset value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: Aptorum Group Ltd Class A maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
Aptorum Group Ltd Class A Industry Peers by Asset Resilience Ratio
Compare Aptorum Group Ltd Class A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Hyloris Developmentsen Sa
BR:HYL |
Biotechnology | 1.36% |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN |
Biotechnology | 0.00% |
|
Oruka Therapeutics, Inc.
NASDAQ:ORKA |
Biotechnology | 53.11% |
|
Gempharmatech Co. Ltd. A
SHG:688046 |
Biotechnology | 23.95% |
|
Vor Biopharma Inc
NASDAQ:VOR |
Biotechnology | 74.48% |
|
Inventiva S.A
PA:IVA |
Biotechnology | 52.73% |
|
Sunmax Biotechnology Co Ltd
TWO:4728 |
Biotechnology | 10.53% |
|
Guangdong VTR Bio-Tech Co Ltd
SHE:300381 |
Biotechnology | 4.98% |
Aptorum Group Ltd Class A Asset Resilience Ratio by Year (2017–2023)
Aptorum Group Ltd Class A asset resilience ratio by year from 2017 to 2023. The table below shows the annual Asset Resilience Ratio data for Aptorum Group Ltd Class A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 0.00% | $0.00 | $20.64 Million | -- |
| 2022-12-31 | 0.49% | $102.48K | $20.87 Million | -0.59pp |
| 2021-12-31 | 1.08% | $236.62K | $21.91 Million | -63.09pp |
| 2020-12-31 | 64.17% | $28.38 Million | $44.23 Million | +59.74pp |
| 2019-12-31 | 4.44% | $1.06 Million | $23.95 Million | +2.19pp |
| 2018-12-31 | 2.25% | $1.01 Million | $45.07 Million | -4.00pp |
| 2017-12-31 | 6.25% | $1.97 Million | $31.56 Million | -- |
About Aptorum Group Ltd Class A
Aptorum Group Limited, through its subsidiaries, a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases. Its pipeline products include SACT-1, a repurposed drug candidate, which is in phase 1 clinical trial to treat neuroblastoma and other cancer types; ALS-4, a repurposed small mol… Read more